Teva Pharmaceutical Industries Limited
Hedge Funds Holdings
Last updated:
Teva Pharmaceutical Industries Limited‘s stocks are currently a part of 417 hedge funds’ portfolios, which represents 46.39% of the total amount of its stocks outstanding. This makes up a total of 513.53M shares of Teva Pharmaceutical Industries Limited. Compared to the previous quarter, the number grew by 1.66% or 8.38M shares more. As for the holding position changes, 32.37% (135) of current hedge fund investors increased the number of shares held, 27.34% (114) of current holders sold a part of the shares held, and 11.75% (49) closed the holdings completely. 44 hedge funds are new holders of Teva Pharmaceutical Industries Limited stock in Q1 2022, it is 10.55% of total holders.
Hedge funds holding Teva Pharmaceutical Industries Limited (Q2 2017 – Q1 2022)
| Q2 2017 | 644 |
|---|---|
| Q3 2017 | 529 |
| Q4 2017 | 498 |
| Q1 2018 | 492 |
| Q2 2018 | 532 |
| Q3 2018 | 545 |
| Q4 2018 | 541 |
| Q1 2019 | 512 |
| Q2 2019 | 440 |
| Q3 2019 | 410 |
| Q4 2019 | 413 |
| Q1 2020 | 438 |
| Q2 2020 | 441 |
| Q3 2020 | 423 |
| Q4 2020 | 428 |
| Q1 2021 | 435 |
| Q2 2021 | 421 |
| Q3 2021 | 408 |
| Q4 2021 | 426 |
| Q1 2022 | 417 |
Hedge funds changes in Teva Pharmaceutical Industries Limited positions (Q2 2017 – Q1 2022)
| Q2 2017 | 58 | 237 | 235 | 83 | 31 |
|---|---|---|---|---|---|
| Q3 2017 | 64 | 171 | 214 | 171 | -91 |
| Q4 2017 | 95 | 126 | 207 | 125 | -55 |
| Q1 2018 | 62 | 131 | 186 | 65 | 48 |
| Q2 2018 | 90 | 173 | 159 | 45 | 65 |
| Q3 2018 | 78 | 168 | 167 | 62 | 70 |
| Q4 2018 | 84 | 167 | 176 | 83 | 31 |
| Q1 2019 | 50 | 160 | 181 | 78 | 43 |
| Q2 2019 | 44 | 159 | 134 | 112 | -9 |
| Q3 2019 | 43 | 118 | 141 | 71 | 37 |
| Q4 2019 | 70 | 123 | 133 | 59 | 28 |
| Q1 2020 | 88 | 146 | 113 | 62 | 29 |
| Q2 2020 | 61 | 129 | 142 | 57 | 52 |
| Q3 2020 | 49 | 124 | 144 | 61 | 45 |
| Q4 2020 | 60 | 126 | 152 | 52 | 38 |
| Q1 2021 | 58 | 125 | 138 | 47 | 67 |
| Q2 2021 | 41 | 127 | 138 | 52 | 63 |
| Q3 2021 | 36 | 119 | 136 | 42 | 75 |
| Q4 2021 | 70 | 127 | 129 | 50 | 50 |
| Q1 2022 | 44 | 135 | 114 | 49 | 75 |
Hedge funds changes in Teva Pharmaceutical Industries Limited stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 378,819,795 | 616,454,570 |
|---|---|---|
| Q3 2017 | 260,761,288 | 514,327,000 |
| Q4 2017 | 1,535,242,400 | 772,827,785 |
| Q1 2018 | 1,359,658,539 | 5,585,880,454 |
| Q2 2018 | 545,015,200 | 682,454,264 |
| Q3 2018 | 527,348,900 | 561,914,892 |
| Q4 2018 | 460,084,980 | 404,984,816 |
| Q1 2019 | 195,567,800 | 291,411,000 |
| Q2 2019 | 134,339,800 | 258,708,518 |
| Q3 2019 | 140,129,800 | 328,874,000 |
| Q4 2019 | 248,576,000 | 487,816,000 |
| Q1 2020 | 226,563,800 | 373,126,000 |
| Q2 2020 | 268,093,100 | 259,107,000 |
| Q3 2020 | 139,051,700 | 174,148,000 |
| Q4 2020 | 164,308,500 | 220,385,000 |
| Q1 2021 | 202,320,000 | 215,184,000 |
| Q2 2021 | 216,213,000 | 265,367,000 |
| Q3 2021 | 231,198,000 | 265,512,000 |
| Q4 2021 | 264,119,000 | 302,281,500 |
| Q1 2022 | 312,718,000 | 296,867,000 |